[HTML][HTML] A cell cycle centric view of tumour dormancy
WA Weston, AR Barr - British Journal of Cancer, 2023 - nature.com
Tumour dormancy and recurrent metastatic cancer remain the greatest clinical challenge for
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
A cell cycle centric view of tumour dormancy
WA Weston, AR Barr - British journal of cancer - pubmed.ncbi.nlm.nih.gov
Tumour dormancy and recurrent metastatic cancer remain the greatest clinical challenge for
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
[HTML][HTML] A cell cycle centric view of tumour dormancy
WA Weston, AR Barr - British Journal of Cancer, 2023 - ncbi.nlm.nih.gov
Tumour dormancy and recurrent metastatic cancer remain the greatest clinical challenge for
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
A cell cycle centric view of tumour dormancy.
WA Weston, AR Barr - British Journal of Cancer, 2023 - europepmc.org
Tumour dormancy and recurrent metastatic cancer remain the greatest clinical challenge for
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
A cell cycle centric view of tumour dormancy.
WA Weston, AR Barr - British Journal of Cancer, 2023 - europepmc.org
Tumour dormancy and recurrent metastatic cancer remain the greatest clinical challenge for
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …
cancer patients. Dormant tumour cells can evade treatment and detection, while retaining …